Indivior PLC Ordinary SharesInvestigation into Indivior's merger with Supernus, where shareholders would own 56.5% of combined company; may seek better terms.
Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed sales of Lantheus Holdings, Atkore, and Indivior Pharmaceuticals are obtaining fair deals for their shareholders. The firm is examining Lantheus Holdings' sale to Curium US Holdings for $102.50 per share in cash plus non-transferable Contingent Value Rights providing up to $12.00 per share in potential additional cash payments, Atkore's sale to Prysmian for $95.00 per share in cash, and Indivior's merger with Supernus Pharmaceuticals in which Indivior shareholders would own approximately 56.5% of the combined company. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages them to contact the firm to discuss their rights at no cost.
Indivior PLC Ordinary SharesInvestigation into Indivior's merger with Supernus, where shareholders would own 56.5% of combined company; may seek better terms.
Lantheus Holdings IncInvestigation into Lantheus's sale to Curium for $102.50 per share plus CVRs; may seek increased consideration or disclosures.
Supernus Pharmaceuticals IncIndivior's merger with Supernus is under investigation; Supernus is the acquirer, potential impact on deal terms.
Atkore International Group IncInvestigation into whether Atkore's sale to Prysmian at $95.00 per share is fair to shareholders; may seek increased consideration.
Prysmian SpAAtkore's sale to Prysmian is under investigation; Prysmian is the acquirer, potential impact on deal terms.